Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AstraZeneca's share price for the quarter that ended in Mar. 2026 was MXN0. AstraZeneca's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 3,101 Mil. Therefore, AstraZeneca's market cap for the quarter that ended in Mar. 2026 was MXN0 Mil.
AstraZeneca's quarterly market cap
increased
from Sep. 2025 (MXN4,331,146 Mil) to Dec. 2025 (MXN5,137,640 Mil) but then
declined
from Dec. 2025 (MXN5,137,640 Mil) to Mar. 2026 (MXN0 Mil).
AstraZeneca's annual market cap
increased
from Dec. 2023 (MXN3,497,167 Mil) to Dec. 2024 (MXN4,142,684 Mil) and
increased
from Dec. 2024 (MXN4,142,684 Mil) to Dec. 2025 (MXN5,137,640 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AstraZeneca's Enterprise Value for Today is MXN5,507,333 Mil.
AstraZeneca (MEX:AZNN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AstraZeneca Market Cap Related Terms
AstraZeneca Market Cap Historical Data
* Premium members only.
The historical data trend for AstraZeneca's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, AstraZeneca's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AstraZeneca Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Market Cap distribution charts can be found below:
* The bar in red indicates where AstraZeneca's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AstraZeneca's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AstraZeneca (MEX:AZNN) has a Market Cap of MXN5,047,728 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AstraZeneca and its competitors. According to the industry distribution chart, AstraZeneca ranks #7 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 0.7%.
Is AstraZeneca's Market Cap too high?
AstraZeneca's current Market Cap is MXN5,047,728 Mil. Based on the distribution chart, AstraZeneca ranks #7 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, AstraZeneca has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, AstraZeneca ranks #7 out of 1024 companies for Market Cap. This places AstraZeneca in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 217.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 217.83, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AstraZeneca and its competitors. For the Drug Manufacturers industry, the median Market Cap is 217.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AstraZeneca's current Market Cap is MXN5,047,728 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
AstraZeneca (MEX:AZNN) has a current Market Cap of MXN5,047,728 Mil. The stock's GF Value™ is MXN1,505.49, compared to a current price of MXN1,628.00 — trading 8.1% above its estimated fair value. The current Market Cap is MXN5,047,728 Mil. AstraZeneca's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AstraZeneca (MEX:AZNN), the current Market Cap is MXN5,047,728 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AstraZeneca (MEX:AZNN) Overvalued in 2026?
Based on GuruFocus' analysis, AstraZeneca stock appears to be overvalued.
The current stock price of MXN1,628.00 is trading 8.1% above its estimated GF Value™ of MXN1,505.49.
Key valuation signals for MEX:AZNN:
Market Cap: MXN5,047,728 Mil
GF Value™: MXN1,505.49 vs. price of MXN1,628.00 (8.1% above fair value)
No single metric tells the full story. See the MEX:AZNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
88GF Score
Get the complete analysis for MEX:AZNN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AZNN has been successfully added to your 
